Join us for an exclusive discussion on cross-border business development strategies for life sciences companies, unlocking critical market opportunities at every stage.

The event will discuss:

– Industry Outlook for Innovation, Regulation and Commercialization
– BIOSECURE Act Coalition: A Coordinated Effort to Influence How the Act is Implemented
– Cross-border Licensing Outlook and Commercialization Strategies for Innovation
– M&A for Biotech and Medtech Assets from the Hong Kong Listing Rules Perspectives
– Evolving Post-listing Financing Landscape and Optimizing Capital Raising Strategies
– Navigating the Highs and Lows in Life Sciences